In re Vascepa Antitrust Litig. Direct Purchaser

Full title: IN RE VASCEPA ANTITRUST LITIGATION DIRECT PURCHASER PLAINTIFFS

Court: United States District Court, D. New Jersey

Date published: Feb 28, 2023

Civil Action 21-12747 (ZNQ) (RLS) (D.N.J. Feb. 28, 2023)

Opinion

Civil Action 21-12747 (ZNQ) (RLS)

02-28-2023

IN RE VASCEPA ANTITRUST LITIGATION DIRECT PURCHASER PLAINTIFFS

QURAISHI, DISTRICT JUDGE

ORDER

QURAISHI, DISTRICT JUDGE

THIS MATTER comes before the Court upon a Motion to Dismiss filed by Defendants Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited, and Amarin Corporation PLC. (ECF No. 30.) The Motion is opposed by Plaintiff KPH Healthcare Services, Inc. For the reasons set forth in the accompanying Opinion, IT IS on this 28^th day of February 2023,

ORDERED that the Motion to Dismiss (ECF No. 30) is hereby DENIED.